Insufficient scRNA-seq data for expression of EID3 at single-cell level.
Insufficient scRNA-seq data for expression of EID3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 217.89 | 180 / 180 | 94% | 3.79 | 405 / 430 |
lung | 100% | 191.88 | 578 / 578 | 94% | 5.59 | 1087 / 1155 |
adrenal gland | 100% | 185.87 | 258 / 258 | 94% | 7.70 | 216 / 230 |
thymus | 99% | 107.06 | 645 / 653 | 95% | 4.04 | 574 / 605 |
prostate | 100% | 189.87 | 244 / 245 | 93% | 3.50 | 466 / 502 |
breast | 100% | 160.69 | 459 / 459 | 92% | 3.76 | 1028 / 1118 |
uterus | 100% | 191.16 | 170 / 170 | 92% | 6.21 | 421 / 459 |
kidney | 99% | 108.61 | 88 / 89 | 91% | 3.67 | 824 / 901 |
esophagus | 93% | 176.05 | 1351 / 1445 | 84% | 3.95 | 154 / 183 |
skin | 100% | 190.78 | 1808 / 1809 | 72% | 3.30 | 340 / 472 |
pancreas | 72% | 36.62 | 236 / 328 | 94% | 3.75 | 167 / 178 |
bladder | 95% | 158.52 | 20 / 21 | 67% | 2.97 | 340 / 504 |
stomach | 96% | 117.06 | 345 / 359 | 65% | 1.63 | 186 / 286 |
brain | 96% | 131.16 | 2549 / 2642 | 64% | 3.00 | 454 / 705 |
intestine | 99% | 168.64 | 953 / 966 | 56% | 1.22 | 295 / 527 |
liver | 69% | 45.52 | 155 / 226 | 40% | 0.98 | 164 / 406 |
spleen | 100% | 195.95 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.09 | 1 / 1 |
adipose | 100% | 162.37 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 144.98 | 1323 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 7.19 | 28 / 29 |
heart | 87% | 76.04 | 749 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 3.76 | 37 / 45 |
peripheral blood | 69% | 63.77 | 639 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 50% | 1.04 | 40 / 80 |
muscle | 27% | 12.90 | 218 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0016925 | Biological process | protein sumoylation |
GO_0006281 | Biological process | DNA repair |
GO_0032204 | Biological process | regulation of telomere maintenance |
GO_0140588 | Biological process | chromatin looping |
GO_0005730 | Cellular component | nucleolus |
GO_0030915 | Cellular component | Smc5-Smc6 complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | EID3 |
Protein name | EP300-interacting inhibitor of differentiation 3 (EID-3) (E1A-like inhibitor of differentiation 3) (EID-1-like inhibitor of differentiation 3) (Non-structural maintenance of chromosomes element 4 homolog B) (NS4EB) (Non-SMC element 4 homolog B) |
Synonyms | |
Description | FUNCTION: Tissue-specific component of the SMC5-SMC6 complex, a complex involved in repair of DNA double-strand breaks by homologous recombination. The complex may promote sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to double-strand breaks. The complex is required for telomere maintenance via recombination and mediates sumoylation of shelterin complex (telosome) components. .; FUNCTION: Acts as a repressor of nuclear receptor-dependent transcription possibly by interfering with CREBBP-dependent coactivation. May function as a coinhibitor of other CREBBP/EP300-dependent transcription factors. . |
Accessions | ENST00000527879.2 Q8N140 |